CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells

SIMPLE SUMMARY: Malignant pleural mesothelioma (MPM) is an aggressive disease affecting the pleura, and its incidence is increasing worldwide. Currently, the recommended systemic therapy for MPM is cisplatin/pemetrexed or immunotherapy with nivolumab and ipilimumab. Unfortunately, the prognosis rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Terenziani, Rita, Galetti, Maricla, La Monica, Silvia, Fumarola, Claudia, Zoppi, Silvia, Alfieri, Roberta, Digiacomo, Graziana, Cavazzoni, Andrea, Cavallo, Delia, Corradi, Massimo, Tiseo, Marcello, Petronini, Pier Giorgio, Bonelli, Mara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739278/
https://www.ncbi.nlm.nih.gov/pubmed/36497412
http://dx.doi.org/10.3390/cancers14235925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739278/
https://www.ncbi.nlm.nih.gov/pubmed/36497412
http://dx.doi.org/10.3390/cancers14235925

Ejemplares similares